Objective To investigate the effects of continuous veno-venous hemofiltration (CVVH) combined with HA330 hemoperfusion (HP) on serum high mobility group protein 1 (HMGB1), high-sensitivity C-reactive protein (hs-CRP), procalcitonin (PCT) and 28-day mortality in post-traumatic sepsis patients with acute kidney injury (AKI). Methods A total of 86 patients with post-traumatic sepsis and AKI treated during February 2020 to March 2021 in Guangzhou Red Cross Hospital Affiliated to Jinan University were retrospectively analyzed. They were divided into CVVH group (43 cases) and HP group (43 cases) according to whether the patient agreed to receive HA330 hemoperfusion treatment. CVVH group received CVVH treatment, and HP group was treated with the HA330 hemoperfusion device on the basis of CVVH. Blood creatinine (Scr), blood urea nitrogen (BUN), serum levels of HMGB1, hs-CRP and PCT, and scores of APACHE Ⅱ and sequential organ failure assessment (SOFA) were recruited from both groups before treatment and after the treatment for 3 and 5 days. 24-hour urine volume and 28-day mortality were recorded. Results After treatment for 3 days and 5 days, the urine volume increased more in HP group than in CVVH group (for 3 days: t=-8.158, P＜0.001; for 5 days: t=-12.954, P＜0.001). Serum levels of Scr, BUN, PCT, hs-CRP and HMGB1, and scores of APACHE Ⅱ and SOFA were significantly lower in HP group than in CVVH group (for 3 days: t=9.698, 3.313, 7.739, 7.266, 2.549, 7.340 and 3.556 respectively, P<0.001, =0.001, <0.001, <0.001, =0.006, <0.001 and <0.001 respectively; for 5 days: t=7.189, 2.385, 14.583, 5.676, 2.797, 11.238 and 6.964 respectively, P<0.001, =0.010, <0.001, <0.001, =0.003, <0.001 and <0.001 respectively). The hospitalization days and mechanical ventilation days were lower in HP group than in CVVH group (for hospitalization days: 12.37±5.11 vs. 20.69±5.04 days, t=9.324, P＜0.001; for mechanical ventilation days: 9.36±2.47 vs. 14.09±2.85 days, t=8.224, P＜0.001). Patients with SOFA score <8 had a lower 28-day mortality rate (5.00% vs. 23.26%, χ2=8.444, P=0.004). Conclusion CVVH combined with HA for the treatment of post-traumatic sepsis patients with AKI can significantly reduce the inflammation responses, promote the recovery of renal function, and reduce the 28-day mortality with better therapeutic effects.
LIANG Wen-Sheng
. Effects of CVVH combined with HA330 hemoperfusion on serum HMGB1, hs-CRP and procalcitonin levels and 28-day mortality in post-traumatic sepsis patients with acute kidney injury [J]. Chinese Journal of Blood Purification, 2022
, 21(05)
: 326
-330
.
DOI: 10.3969/j.issn.1671-4091.2022.05.006
[1]梁华平,朱俊宇,胡明冬. 创伤脓毒症研究领域存在的几个关键问题[J]. 中华创伤杂志,2021,37(5):385-389. DOI:10.3760/cma.j.cn501098-20210208-00124.
[2] Rudd KE, Johnson SC, Agesa KM, et al. Global, regional, and national sepsis incidence and mortality, 1990-2017: analysis for the Global Burden of Disease Study[J]. Lancet. 2020;395(10219):200-211. doi:10.1016/S0140-6736(19)32989-7.
[3]李智鑫,应利君,金烈洲,等. 连续性血液净化治疗对创伤脓毒症患者外周血单核细胞膜型CD14表达及炎症反应的影响[J]. 中华创伤杂志,2018,34(6):540-545. DOI:10.3760/cma.j.issn.1001-8050.2018.06.010.
[4] Peerapornratana S, Manrique-Caballero CL, Gómez H, et al. Acute kidney injury from sepsis: current concepts, epidemiology, pathophysiology, prevention and treatment[J]. Kidney Int. 2019;96(5):1083-1099. doi:10.1016/j.kint.2019.05.026.
[5]Wu J, Ren J, Liu Q, et al. Effects of Changes in the Levels of Damage-Associated Molecular Patterns Following Continuous Veno-Venous Hemofiltration Therapy on Outcomes in Acute Kidney Injury Patients With Sepsis. Front Immunol. 2019;9:3052. Published 2019 Jan 7. doi:10.3389/fimmu.2018.03052.
[6] Singer M, Deutschman CS, Seymour CW, et al. The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3)[J]. JAMA, 2016, 315(8):801-810.
[7] Teles F, de Mendon?a Uch?a JV, Mirelli Barreto Mendon?a D, et al. Acute kidney injury in leptospirosis: the Kidney Disease Improving Global Outcomes (KDIGO) criteria and mortality?. Clin Nephrol. 2016,86(12):303-309.
[8]Paoli CJ, Reynolds MA, Sinha M, et al. Epidemiology and Costs of Sepsis in the United States-An Analysis Based on Timing of Diagnosis and Severity Level[J]. Crit Care Med. 2018,46(12): 1889–97.
[9]Angus DC, van der Poll T. Severe sepsis and septic shock[J]. N Engl J Med. 2013,369(9):
840–51.
[10]Zhou J, Tian H, Du X, et al.; for China Critical Care Clinical Trials Group (CCCCTG). Population-Based Epidemiology of Sepsis in a Subdistrict of Beijing[j].Crit Care Med. 2017,45(7): 1168–76.
[11]张卉,冯永文,姚咏明.深刻理解烧创伤脓毒症发病机制的网络效应[J].中华医学杂志,2020,100(12):881-885. DOI:10.3760/cma.j.cn112137-20191129-02603.
[12]曾小娜,尹连红,许丽娜.脓毒症性急性肾损伤发病机制[J].生理科学进展,2020,51(2):122-126.
[13]江勉君,史忠亮,毛凯凤, 等.氧化应激在脓毒症中的发病机制[J].医学综述,2020,26(5):856-860. DOI:10.3969/j.issn.1006-2084.2020.05.005.
[14]邱玉霞,孙月玲,宫保强,等. 血清高迁移率族蛋白1及白细胞介素-18对老年脓毒症并发急性肾损伤患者的预后评估价值[J]. 中国急救医学,2019,39(10):953-957. DOI:10.3969/j.issn.1002-1949.2019.10.007.
[15]杨静,何浩,谭波,等. 血清TLR4、MFG-E8及HMGB1对脓毒症患者并发急性肾损伤的诊断价值[J]. 山东医药,2020,60(1):30-34. DOI:10.3969/j.issn.1002-266X.2020.01.008.
[16]路坤,何先弟,汪华学,等. 脓毒症相关急性肾损伤在连续肾替代治疗早期降钙素原的预测价值[J]. 蚌埠医学院学报,2020,45(1):60-63. DOI:10.13898/j.cnki.issn.1000-2200.2020.01.015.
[17]王小雨,任立军,沈建飞,等. 血流感染脓毒症患者炎症因子变化、病原菌分布特征及预后影响因素分析[J]. 中国病原生物学杂志,2020,15(5):587-591. DOI:10.13350/j.cjpb.200519.
[18]龚健,刘健,张海明, 等.不同剂量CVVH对脓毒症休克患者预后的影响[J].湖南师范大学学报（医学版）,2018,15(1):162-165. DOI:10.3969/j.issn.1673-016X.2018.01.053.
[19]冯敏,田仁富,邓明强, 等.连续性静脉-静脉血液净化对脓毒症患者血流动力学、凝血功能及免疫功能的影响[J].中国医学装备,2018,15(3):98-102. DOI:10.3969/J.ISSN.1672-8270.2018.03.026.
[20]李依宸,刘娟娟,郭红星,等. 血液灌流治疗内毒素血症机理及研究进展[J]. 国际生物医学工程杂志,2019,42(5):441-445.
[21]Ankawi G, Fan W, Pomarè Montin D,et al. A New Series of Sorbent Devices for Multiple Clinical Purposes: Current Evidence and Future Directions[J]. Blood Purif. 2019,47(1-3):94-100.
[22]Niewiński G, Starczewska M, Kański A. Prognostic scoring systems for mortality in intensive care units – the APACHE model[J]. Anaesthesiol Intensive Ther. 2014,46(1):46–9.
[23]Lie KC, Lau CY, Van Vinh Chau N, West TE, Limmathurotsakul D; for Southeast Asia Infectious Disease Clinical Research Network.Utility of SOFA score, management and outcomes of sepsis in Southeast Asia: a multinational multicenter prospective observational study[J]. J Intensive Care. 2018,6(1): 9.
[24] Huang Z, Wang SR, Su W, Liu JY. Removal of humoral mediators and the effect on the survival of septic patients by hemoperfusion with neutral microporous resin column. Ther Apher Dial. 2010 Dec;14(6):596-602. doi: 10.1111/j.1744-9987.2010.00825.x.
